1. From the Clinical Trials Branch, Division of Epidemiology and Clinical Research, and the
2. The EMMES Corporation, Rockville, Maryland; and the
3. Office of the Clinical Director, National Eye Institute, National Institutes of Health, Bethesda, Maryland;
4. Centers for Disease Control and Prevention, Atlanta, Georgia.